Evidence map›Paper›PMID 31690638›Full record

ArticleJournal of lipid research2020

Germ-free mice exhibit profound gut microbiota-dependent alterations of intestinal endocannabinoidome signaling.

Claudia Manca, Besma Boubertakh, Nadine Leblanc, Thomas Deschênes, Sebastien Lacroix, Cyril Martin, Alain Houde, Alain Veilleux, Nicolas Flamand, Giulio G Muccioli and 4 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05567653 (Effects of 3-month Probiotic Mix Supplementation), which is not on this map. Cited by 95 papers.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05567653 nacompletednot on this mapstarted 2022, after this paper: background citation

Effects of 3-month Probiotic Mix Supplementation (L. Helveticus R-0052, B. Longum R-0175) on Gut Microbiota and Metabolome, Endocannabinoid and Immune Systems Activation, Along With Symptoms of Fatigue in Professional Dancers

TypeinterventionalSponsorPoznan University of Physical EducationRan2022 to 2023Enrolled26ConditionsFatigue, Stress, JobArmsLactobacillus helveticus Rosell-52 and Bifidobacterium longum Rosell-175 (Sanprobi Stress), Starch (placebo)
3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 137 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Defining the Intestinal eCBome and Oxylipin Signaling Systems in a TDP-43 Mouse Model of Frontotemporal Dementia.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Long Term Culture of Germ-Free Zebrafish Using Gamma-Irradiated Feeds.bioRxiv : the preprint server for biology · 2025
    Article
  19. Review
  20. Review

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Claudia MancaCentre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ), Québec, Canada; Département de Médecine, Faculté de Médecine, Université Laval, Québec, Canada; Canada Excellence Research Chair in the Microbiome-Endocannabinoidome Axis in Metabolic Health (CERC-MEND), Québec, Canada.
Besma BoubertakhCentre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ), Québec, Canada; Département de Médecine, Faculté de Médecine, Université Laval, Québec, Canada; Canada Excellence Research Chair in the Microbiome-Endocannabinoidome Axis in Metabolic Health (CERC-MEND), Québec, Canada.
Nadine LeblancCentre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ), Québec, Canada; Canada Excellence Research Chair in the Microbiome-Endocannabinoidome Axis in Metabolic Health (CERC-MEND), Québec, Canada; Institut sur la Nutrition et les Aliments Fonctionnels (INAF), Québec, Canada.
Thomas DeschênesCanada Excellence Research Chair in the Microbiome-Endocannabinoidome Axis in Metabolic Health (CERC-MEND), Québec, Canada; Institut sur la Nutrition et les Aliments Fonctionnels (INAF), Québec, Canada; École de Nutrition, Faculté des Sciences de l'Agriculture et de l'Alimentation (FSAA), Université Laval, Québec, Canada.
Sebastien LacroixCentre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ), Québec, Canada; Canada Excellence Research Chair in the Microbiome-Endocannabinoidome Axis in Metabolic Health (CERC-MEND), Québec, Canada; Institut sur la Nutrition et les Aliments Fonctionnels (INAF), Québec, Canada.
Cyril MartinCentre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ), Québec, Canada; Canada Excellence Research Chair in the Microbiome-Endocannabinoidome Axis in Metabolic Health (CERC-MEND), Québec, Canada.
Alain HoudeCanada Excellence Research Chair in the Microbiome-Endocannabinoidome Axis in Metabolic Health (CERC-MEND), Québec, Canada; Institut sur la Nutrition et les Aliments Fonctionnels (INAF), Québec, Canada.
Alain VeilleuxCanada Excellence Research Chair in the Microbiome-Endocannabinoidome Axis in Metabolic Health (CERC-MEND), Québec, Canada; Institut sur la Nutrition et les Aliments Fonctionnels (INAF), Québec, Canada; École de Nutrition, Faculté des Sciences de l'Agriculture et de l'Alimentation (FSAA), Université Laval, Québec, Canada.
Nicolas FlamandCentre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ), Québec, Canada; Département de Médecine, Faculté de Médecine, Université Laval, Québec, Canada; Canada Excellence Research Chair in the Microbiome-Endocannabinoidome Axis in Metabolic Health (CERC-MEND), Québec, Canada.
Giulio G MuccioliLouvain Drug Research Institute (LDRI), Bioanalysis and Pharmacology of Bioactive Lipids Research Group, UCLouvain (Université Catholique de Louvain), Brussels, Belgium.
Frédéric RaymondCanada Excellence Research Chair in the Microbiome-Endocannabinoidome Axis in Metabolic Health (CERC-MEND), Québec, Canada; Institut sur la Nutrition et les Aliments Fonctionnels (INAF), Québec, Canada; École de Nutrition, Faculté des Sciences de l'Agriculture et de l'Alimentation (FSAA), Université Laval, Québec, Canada.
Patrice D CaniLouvain Drug Research Institute (LDRI), Bioanalysis and Pharmacology of Bioactive Lipids Research Group, UCLouvain (Université Catholique de Louvain), Brussels, Belgium; Walloon Excellence in Life Sciences and Biotechnology (WELBIO), Metabolism and Nutrition Research Group, UCLouvain (Université Catholique de Louvain), Brussels, Belgium.
Vincenzo Di MarzoCentre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ), Québec, Canada; Département de Médecine, Faculté de Médecine, Université Laval, Québec, Canada; Canada Excellence Research Chair in the Microbiome-Endocannabinoidome Axis in Metabolic Health (CERC-MEND), Québec, Canada; Institut sur la Nutrition et les Aliments Fonctionnels (INAF), Québec, Canada; École de Nutrition, Faculté des Sciences de l'Agriculture et de l'Alimentation (FSAA), Université Laval, Québec, Canada.
Cristoforo SilvestriCentre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ), Québec, Canada; Département de Médecine, Faculté de Médecine, Université Laval, Québec, Canada; Canada Excellence Research Chair in the Microbiome-Endocannabinoidome Axis in Metabolic Health (CERC-MEND), Québec, Canada. Electronic address: cristoforo.silvestri@criucpq.ulaval.ca.
Institut universitaire de cardiologie et de pneumologie de Québec · CAUniversité Laval · CAUCLouvain · BEUniversité du Québec · CAWalloon Excellence in Lifesciences and Biotechnology · BE

Funding

CIHR
6 · The paper itself

Abstract

The gut microbiota is a unique ecosystem of microorganisms interacting with the host through several biochemical mechanisms. The endocannabinoidome (eCBome), a complex signaling system including the endocannabinoid system, approximately 50 receptors and metabolic enzymes, and more than 20 lipid mediators with important physiopathologic functions, modulates gastrointestinal tract function and may mediate host cell-microbe communications there. Germ-free (GF) mice, which lack an intestinal microbiome and so differ drastically from conventionally raised (CR) mice, offer a unique opportunity to explore the eCBome in a microbe-free model and in the presence of a reintroduced functional gut microbiome through fecal microbiota transplant (FMT). We aimed to gain direct evidence for a link between the microbiome and eCBome systems by investigating eCBome alterations in the gut in GF mice before and after FMT. Basal eCBome gene expression and lipid profiles were measured in various segments of the intestine of GF and CR mice at juvenile and adult ages using targeted quantitative PCR transcriptomics and LC-MS/MS lipidomics. GF mice exhibited age-dependent modifications in intestinal eCBome gene expression and lipid mediator levels. FMT from CR donor mice to age-matched GF male mice reversed several of these alterations, particularly in the ileum and jejunum, after only 1 week, demonstrating that the gut microbiome directly impacts the host eCBome and providing a cause-effect relationship between the presence or absence of intestinal microbes and eCBome signaling. These results open the way to new studies investigating the mechanisms through which intestinal microorganisms exploit eCBome signaling to exert some of their physiopathologic functions.

Indexed as

Gastrointestinal MicrobiomeSignal TransductionAnimalsEndocannabinoidsIntestinesMaleMiceMice, Inbred C57BLEndocannabinoidsendocannabinoidsfecal microbiota transplantgene expressiongerm-free phenotypegut microbiomeintestinelipidomics.

Identifiers

PMID31690638
PMCPMC6939599
OpenAlexW2985018913

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.